Intezyne, Inc.
Developing a pipeline of oncology products, including two clinical stage compounds originated by Niiki Pharma which target pathways in the endoplasmic reticulum in cancer cells.
Active Portfolio Company
Developing a pipeline of oncology products, including two clinical stage compounds originated by Niiki Pharma which target pathways in the endoplasmic reticulum in cancer cells.
Active Portfolio Company